JPMorgan Chase & Co vs Altria Group Inc — how do they compare? JPMorgan Chase & Co trades at $362.35 (market cap $956.39B), while Altria Group Inc trades at $65.03 (market cap $114.13B). The key difference: JPMorgan Chase & Co is far larger — about 8.4× Altria Group Inc's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals.
| JPM | MO | |
|---|---|---|
Market Cap | $956.39B | $114.13B |
Volume | 10,479,943 | — |
Sector | Financials | Consumer Staples |
52-Week High | $359.79 | $74.92 |
52-Week Low | $282.84 | $54.72 |
Dividend Yield | 1.67% | 6.2% |
Enterprise Value | — | $136.34B |
Signals from Pluang's Aura AI — not financial advice
JPMorgan Chase (JPM) trades at $362.04, up 1.26% today, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q1 and Q2 2026, with net income margin at 33.38% and ROE of 18.43%. The stock shows robust fundamentals, including a P/E of 15.42 and consensus price target of $374.18. Cash flow trends indicate significant financing activities, while geopolitical and cybersecurity risks are noted in recent news.
The outlook for JPM remains positive, driven by earnings momentum and institutional confidence. Key risks include macroeconomic volatility and regulatory challenges. With a moderate buy consensus and strong profitability metrics, the stock presents a solid opportunity for growth-oriented investors, though vigilance on external risks is warranted.
Altria Group (MO) trades at $68.35, up 0.89% with mixed technical signals showing bearish moving averages but oversold RSI levels. The company maintains strong profitability with 39% net income margin and $6.95B net income for 2025, though revenue declined slightly to $20.14B. Recent earnings show alternating beats and misses, with Q3 2026 results pending. Analyst consensus remains bullish with 61.5% buy ratings and $71.50 price target, while the stock offers a 6.3% dividend yield with 56 consecutive annual increases expected.
MO presents value opportunity with 14.4x P/E ratio and strong cash flow generation, but faces headwinds from cigarette volume declines and regulatory pressures. The smoke-free product transition shows progress but remains early stage. Current price near support at $67 suggests limited downside, while analyst targets indicate 4.6% upside potential. Key risks include litigation exposure and slower-than-expected diversification from traditional tobacco products.
Trailing returns across standard periods
Latest headlines on both assets
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →